1. Home
  2. KMTS

as 06-20-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

NYSE

Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.

Founded: 2014 Country:
United States
United States
Employees: N/A City: KIRKLAND
Market Cap: 1.0B IPO Year: 2025
Target Price: $27.00 AVG Volume (30 days): 156.9K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -898.50 EPS Growth: N/A
52 Week Low/High: $14.15 - $26.15 Next Earning Date: 07-13-2025
Revenue: $52,636,000 Revenue Growth: 589.86%
Revenue Growth (this year): 113.57% Revenue Growth (next year): 42.47%

Share on Social Networks: